Technology | December 19, 2014

Volpara Solutions Launches VolparaDensity 3.0 for 2-D and 3-D Breast Density Assessment

Software suitable for use with digital mammography and digital breast tomosynthesis

Volpara, VolparaDensity, version 3.0, RSNA 2014

Image courtesy of Volpara Solutions

December 19, 2014 – Volpara Solutions announced the launch of the VolparaDensity version 3.0 breast density assessment tool at the 100th annual meeting of the Radiological Society of North America (RSNA), Nov. 30-Dec. 5 in Chicago. Available clinically for use with digital breast tomosynthesis datasets from multiple manufacturers, the system is already in use at Peninsula Diagnostic Imaging in San Mateo, Calif., and Santa Barbara Women’s Imaging in Santa Barbara, Calif. 

VolparaDensity for use with Hologic tomosynthesis systems will be available immediately and the new version for use with GE and Siemens tomosynthesis units will be available in early 2015.

A digital breast tomosynthesis exam, sometimes called a 3-D mammogram, is performed similarly to a traditional mammogram where the technologist compresses the breast and acquires images from different angles. Tomosynthesis is a multi-view mammography technique where each of the individual tomosynthesis projections acquired is a low dose, 2-D projection mammogram.

“We screen patients with dense breasts with 3-D tomosynthesis while women with fatty breasts continue to get conventional 2-D digital mammography because of the lower dose. We are excited to have the option of providing objective, volumetric breast density for all of our patients as the ability to provide consistent and accurate breast density values is critical to proper patient management. Breast density assessment should be the same no matter if the image was acquired using 2-D or 3-D.  It is, after all, the same breast, so it is very reassuring that VolparaDensity has been highly correlated between mammography and tomosynthesis,” said Susan Marks, M.D., director of breast imaging at Peninsula Diagnostic Imaging.

The VolparaDensity software, which has been in clinical use since 2010, was developed to be suitable for use with both digital mammography and digital breast tomosynthesis data from any manufacturer. It uses the same algorithm to process both the acquired tomosynthesis projections and the raw data of a conventional 2-D mammogram,  and also reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and synthetic 2-D images (C-View from Hologic, V-Preview from GE) and enables consistent density assessments based on each patient’s actual breast tissue composition.

“Informing women about their breast density is critical to their ability to make informed decisions about their breast health. By providing reproducible and consistent volumetric density for 3-D tomosynthesis, VolparaDensity helps improve screening for women with dense breasts by enabling radiologists to more systematically determine which patients would benefit from supplemental imaging such as automated breast ultrasound,” said Judy Dean, M.D., senior radiologist, Santa Barbara Women’s Imaging.

VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening. Highly correlated to breast magnteic resonance (MR) assessments, VolparaDensity automatically generates an objective measurement of volumetric breast density correlated to the American College of Radiology (ACR) breast density categories.

For more information: www.volparasolutons.com

Related Content

News | Artificial Intelligence | November 18, 2019
November 18, 2019 — Visage Imaging, Inc. (Visage), a wholly owned subsidi
 Mammography doctor
News | Breast Imaging | November 12, 2019
November 12, 2019 — Geisinger has partnered with...
Kubtec has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut
News | Radiology Business | November 06, 2019
November 6, 2019 — The Connecticut Technology Council (CTC) and...
The U.S. market is unique in that it formed over 55 percent of the global market in 2018

The U.S. market is unique in that it formed over 55 percent of the global market in 2018.

Feature | Mammography | October 30, 2019 | By Imogen Fitt
When breast imaging comes to mind, mammography is the undisputed current modality of choice.
2-D mole marker

2-D mole marker used in 3-D, Slice 1 of 59

Sponsored Content | Case Study | Breast Imaging | October 30, 2019
When it comes to the use of mammography skin markers in dig...
Breast Tomosynthesis Increases Cancer Detection Over Digital Mammography
News | Mammography | October 23, 2019
Screening digital breast tomosynthesis (DBT) results in “significantly increased CDR [cancer detection rates]” compared...
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
GE Healthcare and Premier Inc. Developing One-stop Breast Clinic Model for U.S.
News | Mammography | October 21, 2019
GE Healthcare and Premier Inc. have announced a collaboration to develop a model to bring a same-day breast cancer...